Tailored therapy for heart failure: neurohormones. - Wikidata - wikimedia - TriplyDB

Tailored therapy for heart failure: neurohormones.

Tailored therapy for heart failure: neurohormones.

http://www.wikidata.org/entity/Q37910927

about

Evaluation of red blood cell distribution width as a prognostic indicator in cats with acquired heart disease, with and without congestive heart failure.Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure.

P2860

Q38862500-AA11330F-39BB-4E93-843E-C1438D84A7EB Q42260678-B43006E0-6E70-423D-9464-921BFB554775

P2860

Tailored therapy for heart failure: neurohormones.

http://www.wikidata.org/entity/Q37910927

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Tailored therapy for heart failure: neurohormones.

@en

Tailored therapy for heart failure: neurohormones.

@nl

type

label

Tailored therapy for heart failure: neurohormones.

@en

Tailored therapy for heart failure: neurohormones.

@nl

prefLabel

Tailored therapy for heart failure: neurohormones.

@en

Tailored therapy for heart failure: neurohormones.

@nl

P1433

Q37910927-F62D4DF6-4731-46F4-A472-7C311DA1D9A5

P1476

Q37910927-0A7C9098-EA5F-49DC-9FB2-FCC4D724C116

P2093

Q37910927-80799B9A-9F09-4168-8D35-E86A15C6CB2B

P2860

Q37910927-1258ABAA-87BC-41BA-ABDC-9D5EE98724F0

Q37910927-12C4C91E-7D63-470C-929A-E5E97B38E589

Q37910927-268101E8-A0F4-49BE-B8EB-D8F6D5C84DFD

Q37910927-298473DE-5CCA-4387-9ECE-340439A7B37E

Q37910927-3119CA15-3A41-420F-8964-A03EF575612E

Q37910927-6F4F029B-E9F1-4142-9FEB-C99E853119A0

Q37910927-7CCE84CD-4DDE-4055-BF8E-1301950A2D7B

Q37910927-85B4E9D0-F834-4529-8791-E894D0335448

Q37910927-953C263E-3708-45B1-B93D-84E870B188FE

Q37910927-95591BD0-28E4-46A6-B32B-9F411B8AC039

P304

Q37910927-6B201B3D-922D-49E8-88EB-B4F6D7F70557

P31

Q37910927-5B6C3370-F3A6-4322-B73F-BB8A0C516F29

P356

Q37910927-9883B334-A360-49C5-8B83-7EC3A9C0CBFA

P433

Q37910927-CAB91E0A-0E0C-4E6E-A774-22D255D20275

P478

Q37910927-225DB536-B5C7-4351-BAB2-7A4B3A4C67C3

P577

Q37910927-8C044F03-E8AD-41C0-B3FA-81E692418741

P698

Q37910927-6B50F7FB-E96F-4A7D-B857-368BEC87E32B

P921

Q37910927-3E9CC4F4-D4A4-4242-921E-EE674E249092

P356

P1433

Canadian Journal of Physiology and Pharmacology

P1476

Tailored therapy for heart failure: neurohormones.

@en

P2093

A Mark Richards

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of medications on circulating levels of cardiac natriuretic peptides

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.

Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.

Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality

N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

P304

603-607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/Y11-036

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21812619

http://www.w3.org/2001/XMLSchema#string

P921